Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02146599 · ClinicalTrials.gov registry record
Patient Perception of Visual Quality and Function
A clinical trial, sponsored by Abbott Medical Optics.
- Completed
- Registry status
- 301
- Enrollment target
NCT02146599: Completed study, sponsored by Abbott Medical Optics.
NCT02146599 is a clinical trial that has completed, run by Abbott Medical Optics. The registered enrollment target is 301 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02146599 has completed, sponsored by Abbott Medical Optics.
- COMPLETED
- Registry status
- 301 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the visual quality and function of pseudophakic patients.
Primary Outcome
Patients will be assessed at a baseline visit and a visit 1 week later to determine their use of corrective visual aids (i.e., spectacles, contact lenses) post Intraocular Lens (IOL) surgery.
Interventions
- OTHER Administration of patient self-assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 301 participants |
| Start Date | 2014-05 |
| Est. Completion | 2014-07 |
What the finished NCT02146599 record still lists
NCT02146599 is an observational study that tracks outcomes without assigning an intervention. The registered 301 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Administration of patient self-assessment is the first listed.
NCT02146599 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02146599 about?
NCT02146599 is a clinical study titled "Patient Perception of Visual Quality and Function". The purpose of this study is to evaluate the visual quality and function of pseudophakic patients.
What is the current status of trial NCT02146599?
This trial is currently completed. The enrollment target is 301 participants. The study started on 2014-05. Estimated completion is 2014-07.
What interventions are being tested in trial NCT02146599?
The interventions under investigation include: Administration of patient self-assessment (OTHER).
Who is sponsoring clinical trial NCT02146599?
This trial is sponsored by Abbott Medical Optics, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005975 · 301 participants · Phase 3
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia